These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis. Knopp P, Krom YD, Banerji CR, Panamarova M, Moyle LA, den Hamer B, van der Maarel SM, Zammit PS. J Cell Sci; 2016 Oct 15; 129(20):3816-3831. PubMed ID: 27744317 [Abstract] [Full Text] [Related]
28. Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Lemmers RJ, Van Overveld PG, Sandkuijl LA, Vrieling H, Padberg GW, Frants RR, van der Maarel SM. Am J Hum Genet; 2004 Jul 15; 75(1):44-53. PubMed ID: 15154112 [Abstract] [Full Text] [Related]
29. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, Kimonis VE, Balog J, Frants RR, Ball AR, Lock LF, Donovan PJ, van der Maarel SM, Yokomori K. PLoS Genet; 2009 Jul 15; 5(7):e1000559. PubMed ID: 19593370 [Abstract] [Full Text] [Related]
32. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. van der Maarel SM, Tawil R, Tapscott SJ. Trends Mol Med; 2011 May 15; 17(5):252-8. PubMed ID: 21288772 [Abstract] [Full Text] [Related]
33. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD). Dai Y, Li P, Wang Z, Liang F, Yang F, Fang L, Huang Y, Huang S, Zhou J, Wang D, Cui L, Wang K. J Med Genet; 2020 Feb 15; 57(2):109-120. PubMed ID: 31506324 [Abstract] [Full Text] [Related]
36. Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy. Buzhov BT, Lemmers RJ, Tournev I, van der Wielen MJ, Ishpekova B, Petkov R, Petrova J, Frants RR, Padberg GW, van der Maarel SM. Neuromuscul Disord; 2005 Jul 15; 15(7):471-5. PubMed ID: 15935668 [Abstract] [Full Text] [Related]
38. CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy. Himeda CL, Jones TI, Jones PL. Mol Ther; 2016 Mar 15; 24(3):527-35. PubMed ID: 26527377 [Abstract] [Full Text] [Related]
39. Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy. Himeda CL, Jones TI, Virbasius CM, Zhu LJ, Green MR, Jones PL. Mol Ther; 2018 Jul 05; 26(7):1797-1807. PubMed ID: 29759937 [Abstract] [Full Text] [Related]
40. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy. Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP, Miller JB, Wagner KR, Jones PL. Clin Epigenetics; 2015 Jul 05; 7(1):37. PubMed ID: 25904990 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]